Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dementia workup. Deciding on laboratory testing for the elderly

C Frank1

  • 1Queen's University, Division of Geriatric Medicine, St Mary's of the Lake Hospital, Kingston, ON.

Canadian Family Physician Medecin De Famille Canadien
|July 25, 1998
PubMed
Summary

This study reviewed guidelines for laboratory testing in dementia patients and aimed to help family physicians decide which tests to use. The CCCAD guidelines recommend core tests like blood count and thyroid levels, with some tests used selectively based on clinical signs. The study found that most recommendations come from consensus rather than strong evidence. Prospective studies suggest relying on clinical judgment. The lower prevalence of reversible dementia supports a selective testing approach. The goal remains to identify reversible causes and factors that worsen dementia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomechanical and histological variables differ by site but not by lameness in equine digital cushion samples from forelimbs.

Journal of equine veterinary science·2024
Same author

Flemish network on rare connective tissue diseases (CTD): patient pathways in systemic sclerosis. First steps taken.

Acta clinica Belgica·2023
Same author

High inter- and intra-observer agreement in mapping sequences compared to classical Lake Louise Criteria assessment of myocarditis by inexperienced observers.

Clinical radiology·2020
Same author

Hybrid triad provides fracture plane stability in a computational model of a Pauwels Type III hip fracture.

Computer methods in biomechanics and biomedical engineering·2020
Same author

Disentangling outbreaks using whole-genome sequencing: concurrent multistate outbreaks of <i>Salmonella</i> Kottbus in Germany, 2017.

Epidemiology and infection·2020
Same author

Recurrent outbreaks caused by the same Salmonella enterica serovar Infantis clone in a German rehabilitation oncology clinic from 2002 to 2009.

The Journal of hospital infection·2018

Area of Science:

  • Geriatric medicine
  • Neurological diagnostics
  • Clinical decision-making in dementia

Background:

Family physicians often lack awareness of established guidelines for dementia workup. Prior research has shown that general diagnostic approaches for dementia include a range of laboratory tests. However, the effectiveness of these tests in identifying reversible causes remains unclear. Some evidence suggests that not all tests are equally useful in every clinical scenario. The need for targeted investigations has been highlighted by recent studies. The CCCAD guidelines propose a selective testing strategy. This gap motivated a review of evidence to better inform clinical practice. That uncertainty drove the need to assess the validity of CCCAD recommendations.

Purpose Of The Study:

This study aimed to evaluate the CCCAD guidelines for dementia laboratory testing. The goal was to determine their relevance for family physicians. The specific problem involved unclear evidence supporting certain tests. The motivation was to clarify which investigations are most useful. The study focused on evidence from 1992 to 1997. It sought to bridge the gap between guidelines and clinical practice. The authors proposed to assess the strength of evidence for each test. They wanted to guide physicians in selecting appropriate investigations.

Keywords:
Dementia diagnosisGeriatric testingClinical decision-makingNeurological investigations

Frequently Asked Questions

The CCCAD guidelines recommend a complete blood count, electrolytes, glucose, calcium, and thyroid levels as core tests.

Vitamin B12 testing is recommended when the clinical situation warrants it, according to CCCAD guidelines.

A head CT scan is included to detect structural causes of dementia when clinical signs suggest it.

Syphilis testing is recommended selectively when clinical suspicion is present, based on CCCAD guidelines.

The CCCAD core tests have C-level evidence, while most recommendations come from consensus rather than controlled trials.

Related Experiment Videos

Main Methods:

The researchers used MEDLINE to search for relevant English-language articles. They focused on studies published between 1992 and March 1997. MeSH terms like dementia and cognition were used in the search. Keywords for specific tests, such as vitamin B12 and syphilis, were also included. Both prospective and retrospective studies were considered. Articles reviewing general dementia investigations were included. The study reviewed evidence for CCCAD core investigations. It evaluated the sensitivity and specificity of specific tests.

Main Results:

The CCCAD core tests included blood count, electrolytes, glucose, calcium, and thyroid levels. These tests had C-level evidence supporting their use. B12 levels, head CT scans, and syphilis testing were recommended selectively. Prospective studies suggested relying on clinical judgment for test selection. No controlled trials supported CCCAD recommendations directly. Most guidance came from consensus rather than strong evidence. The prevalence of reversible dementia was found to be lower than expected. This finding supports a more selective testing approach.

Conclusions:

The CCCAD guidelines are supported by available literature on dementia workup. The core tests are recommended based on C-level evidence. Selective testing is advised when clinical signs suggest specific conditions. The authors proposed that physicians use clinical judgment in test selection. No controlled trials provided strong evidence for CCCAD recommendations. The lower prevalence of reversible dementia supports a selective approach. Identification of reversible causes remains a primary goal. The study emphasizes the need for targeted investigations in dementia.

Failed At:

2026-07-14T07:45:22.464505+00:00

The lower prevalence of reversible dementia supports a selective approach to investigations, as proposed by the authors.